A year and a half ago, Albert Freund was on his way to work and began feeling a slight pain in his chest, which grew worse. “I broke out into a sweat and the pain got real stiff in my arm,” he said.

Among patients with minor ischemic stroke or transient ischemic attack (TIA), clopidogrel does not appear to give additional benefit over aspirin in terms of reduced risk for new stroke in patients ...

Clinicians should offer a genetic test to people who have had an ischaemic stroke or transient ischaemic attack to determine whether they can be treated with the drug clopidogrel to reduce the risk of ...

NORTHBROOK, Ill., June 21, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH) announced today it will provide additional information for its premarket approval (PMA) application following the ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Performing a genetic test for nonresponse to clopidogrel often influenced physician choice of ...

In many patients with stable coronary artery disease (CAD), platelet reactivity varies markedly over time despite an unchanged dose of clopidogrel, according to a subanalysis of the ELEVATE-TIMI 56 ...

LONDON, May 11 (Reuters) - AstraZeneca Plc's experimental heart drug Brilinta has beaten Sanofi-Aventis SA and Bristol-Myers Squibb Co's blockbuster Plavix in a pivotal clinical trial, lifting its ...

The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner. Subscribe to read this story ad ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix&reg ...

LONDON (Reuters) - AstraZeneca Plc's experimental heart drug Brilinta has beaten Sanofi-Aventis SA and Bristol-Myers Squibb Co's blockbuster Plavix in a pivotal clinical trial, lifting its shares ...